161 related articles for article (PubMed ID: 30129138)
1. Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogs.
Taniguchi S; Yano T; Imaizumi M; Manabe N
Neurogastroenterol Motil; 2018 Dec; 30(12):e13448. PubMed ID: 30129138
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory action of mitemcinal (GM-611), an acid-resistant non-peptide motilin receptor agonist, on colonic motor activity and defecation: spontaneous and mitemcinal-induced giant migrating contractions during defecation in dogs.
Hirabayashi T; Morikawa Y; Matsufuji H; Hoshino K; Hagane K; Ozaki K
Neurogastroenterol Motil; 2009 Oct; 21(10):1085-e91. PubMed ID: 19508333
[TBL] [Abstract][Full Text] [Related]
3. Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study.
Kamei D; Kamei Y; Nagano M; Mineshima M; Nitta K; Tsuchiya K
BMC Gastroenterol; 2020 Jan; 20(1):26. PubMed ID: 32005162
[TBL] [Abstract][Full Text] [Related]
4. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
Nakajima A; Seki M; Taniguchi S
J Gastroenterol; 2018 Apr; 53(4):525-534. PubMed ID: 28840422
[TBL] [Abstract][Full Text] [Related]
5. Elobixibat for the treatment of constipation.
Chedid V; Vijayvargiya P; Camilleri M
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):951-960. PubMed ID: 30204504
[TBL] [Abstract][Full Text] [Related]
6. Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.
Kumagai Y; Amano H; Sasaki Y; Nakagawa C; Maeda M; Oikawa I; Furuie H
Br J Clin Pharmacol; 2018 Oct; 84(10):2393-2404. PubMed ID: 29959787
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological characteristics and clinical study results of ileal bile acid transporter inhibitor elobixibat (GOOFICE
Ikeda N; Taniguchi S; Seki M
Nihon Yakurigaku Zasshi; 2019; 153(3):129-138. PubMed ID: 30867382
[TBL] [Abstract][Full Text] [Related]
8. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota.
Misawa N; Higurashi T; Takatsu T; Iwaki M; Kobayashi T; Yoshihara T; Ashikari K; Kessoku T; Fuyuki A; Matsuura T; Ohkubo H; Usuda H; Wada K; Naritaka N; Takei H; Nittono H; Matsumoto M; Honda A; Nakajima A; Camilleri M
Aliment Pharmacol Ther; 2020 Sep; 52(5):821-828. PubMed ID: 32687674
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.
Mosińska P; Fichna J; Storr M
World J Gastroenterol; 2015 Jun; 21(24):7436-42. PubMed ID: 26139989
[TBL] [Abstract][Full Text] [Related]
10. DSP-6952, a novel 5-HT
Mine Y; Itakura T; Oku S; Asada R; Shimizu I
Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
[TBL] [Abstract][Full Text] [Related]
11. Effects of Calcitonin Gene-Related Peptide on Colonic Motility and Defecation in Conscious Dogs.
Ono T; Nagao M; Imoto H; Watanabe K; Tanaka N; Motoi F; Naitoh T; Unno M
J Gastrointest Surg; 2018 Dec; 22(12):2097-2103. PubMed ID: 29980973
[TBL] [Abstract][Full Text] [Related]
12. Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation.
Miner PB
Expert Opin Pharmacother; 2018 Aug; 19(12):1381-1388. PubMed ID: 30129377
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
[TBL] [Abstract][Full Text] [Related]
14. Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
Nakajima A; Ishizaki S; Matsuda K; Kurosu S; Taniguchi S; Gillberg PG; Mattsson JP; Hasunuma T; Camilleri M
J Gastroenterol Hepatol; 2022 May; 37(5):883-890. PubMed ID: 35168298
[TBL] [Abstract][Full Text] [Related]
15. Intracolonic capsaicin stimulates colonic motility and defecation in conscious dogs.
Hayashi K; Shibata C; Nagao M; Sato M; Kakyo M; Kinouchi M; Saijo F; Miura K; Ogawa H; Sasaki I
Surgery; 2010 Jun; 147(6):789-97. PubMed ID: 20079916
[TBL] [Abstract][Full Text] [Related]
16. Intracolonic Administration of the TRPA1 Agonist Allyl Isothiocyanate Stimulates Colonic Motility and Defecation in Conscious Dogs.
Someya S; Nagao M; Shibata C; Tanaka N; Sasaki H; Kikuchi D; Miyachi T; Naitoh T; Unno M
J Gastrointest Surg; 2015 Jul; 19(7):1342-9. PubMed ID: 25855335
[TBL] [Abstract][Full Text] [Related]
17. Giant migrating contractions during defecation in the dog colon.
Karaus M; Sarna SK
Gastroenterology; 1987 Apr; 92(4):925-33. PubMed ID: 3556998
[TBL] [Abstract][Full Text] [Related]
18. Effect of SC-435 on the gastrointestinal migrating myoelectric complex in guinea pigs.
Zhang XM; Dong L; Liu LN; Lei YM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):497-503. PubMed ID: 16320575
[TBL] [Abstract][Full Text] [Related]
19. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice.
Yamauchi R; Takedatsu H; Yokoyama K; Yamauchi E; Kawashima M; Nagata T; Uchida Y; Kitaguchi T; Higashi T; Fukuda H; Tsuchiya N; Takata K; Tanaka T; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Hepatol Int; 2021 Apr; 15(2):392-404. PubMed ID: 33398776
[TBL] [Abstract][Full Text] [Related]
20. Effects of physical exercise on colonic motor activity.
Dapoigny M; Sarna SK
Am J Physiol; 1991 Apr; 260(4 Pt 1):G646-52. PubMed ID: 2018138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
